Exact's stock is rated a buy and will soon return to the 9-10 range in a few months and could skyrocket to 13 with Positive Clinical Trial News. There really is no quick buck when it comes to stock investing. It happens, and it can happen, but more times than not, these things take time.
On other news Avanir's Stock (AVNR) has declined sharply in afterhours saying they have not heard from the FDA and is anticipating news concerning their approval for psuedobulbar affect. I am expecting a CRL from the FDA and no approval and this would be devastating to Avanir Shareholders. But it could get approved. It does have a fighting chance.
In other news Vivus receives a CRL for Qnexa and the share price has gone up. That one I really don't get but investors sometimes don't know what they are getting themselves into. Sure if approved it would be monumental, but I don't see that happening anytime soon. Vivus' shares are up 26.43% at 7.75. Today it gained 1.62 points. I don't see this ride ending well for investors but what do I know. I am baffled at the stock market right now.
Wikinvest--Exact Sciences (EXAS)
Wikinvest--Avanir (AVNR)
Wikinvest--Vivus (VVUS)